Dyax Corp. (DYAX) Sells 7.4M Shares at $2.02
Dyax Corp. (NASDAQ: DYAX) agreed to sell 7,425,743 shares of its common stock at a price of $2.02 per share in an underwritten public offering with no warrants. The price per share is equal to the closing price of Dyax’s common stock on June 24, 2009.
Deutsche Bank Securities Inc. is the sole underwriter for the offering.
Dyax intends to use the net proceeds from the offering to fund the development and commercialization of DX-88, the Company’s ongoing research and preclinical activities, and for general corporate purposes
Deutsche Bank Securities Inc. is the sole underwriter for the offering.
Dyax intends to use the net proceeds from the offering to fund the development and commercialization of DX-88, the Company’s ongoing research and preclinical activities, and for general corporate purposes
You May Also Be Interested In
- Dyax Launches HAE Diagnostic Testing Refund Program to Encourage Proper Diagnosis and Disease Management
- New York Mortgage Trust (NYMT) Announces 4M Common Offering
- Christopher & Banks (CBK) Files $75M Mixed Shelf
Create E-mail Alert Related Categories
Equity OfferingsRelated Entities
Deutsche BankSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
